In vivo cyclin e expression as a marker for early cervical neoplasia

Modern Pathology

Volumn 11, Issue 12, 1998, Pages 1238-1246

  Quade, Bradley J ^a   Park, Jeong Ja ^a   Crum, Christopher P ^a   Sun, Deqin ^a   Dutta, Anindya ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

Cervical neoplasia; Cyclin E; Human papillomavirus; Squamous intraepithelial lesion

Indexed keywords

CYCLIN E; KI 67 ANTIGEN; NUCLEIC ACID; VIRUS DNA;

ARTICLE; CANCER GRADING; CANCER INVASION; CONTROLLED STUDY; EARLY CANCER; FEMALE; HUMAN; HUMAN TISSUE; IN VIVO STUDY; PRIORITY JOURNAL; UTERINE CERVIX BIOPSY; UTERINE CERVIX CARCINOMA; UTERINE CERVIX CARCINOMA IN SITU; WART VIRUS;

CARCINOMA, SQUAMOUS CELL; CELL NUCLEUS; CERVICAL INTRAEPITHELIAL NEOPLASIA; CYCLIN E; DNA, VIRAL; FEMALE; HUMANS; KI-67 ANTIGEN; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; PRECANCEROUS CONDITIONS; TUMOR MARKERS, BIOLOGICAL; TUMOR VIRUS INFECTIONS; UTERINE CERVICAL NEOPLASMS;

EID: 0032417029     PISSN: 08933952     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (35)

1. Crum CP, Cibas ES, Lee KR. Viral pathogenesis and natural history of cervical neoplasia. In: Pathology of early cervical neoplasia. New York: Churchill Livingstone; 1997. p. 7-27.
2. Crum CP, Cibas ES, Lee KR. Historical perspective. In: Pathology of early cervical neoplasia. New York: Churchill Livingstone; 1997. p. 1-6.
3. Cotran RS, Kumar V, Robbins SL. Female genital tract. In. Pathologic basis of disease. 4th ed. Philadelphia: Saunders; 1989. p. 1141.
4. Resnick M, Lester S, Tate JE, Sheets EE, Sparks C, Crum CP. Viral and histopathologic correlates of MN and MIB-1 expression in cervical intraepithelial neoplasia. Hum Pathol 1996;27:234-9.
5. Chellappan S, Kraus VB, Kroger B, Munger K, Howley PM, Phelps WC, et al. Adenovirus ElA, simian virus 40 tumor antigen, and human papillomavirus E7 protein share the capacity to disrupt the interaction between transcription factor E2F and the retinoblastoma gene product. Proc Natl Acad Sci U S A 1992;89:4549-53.
6. Howley PM, Scheffner M, Huibregtse J, Munger K. Oncoproteins encoded by the cancer-associated human papillomaviruses target the products of the retinoblastoma and p53 tumor suppressor genes. Cold Spring Harb Symp Quant Biol 1991;56:149-55.
7. Hu G, Liu W, Hanania EG, Fu S, Wang T, Deisseroth AB. Suppression of tumorigenesis by transcription units expressing the antisense E6 and E7 messenger RNA (mRNA) for the transforming proteins of the human papillomavirus and the sense mRNA for the retinoblastoma gene in cervical carcinoma cells. Cancer Gene Ther 1995;2:19-32.
8. Scheffner M, Munger K, Byrne JC, Howley PM. The state of the p53 and retinoblastoma genes in human cervical carcinoma cell lines. Proc Natl Acad Sci U S A 1991;88:5523-7.
9. Slebos RJ, Lee MH, Plunkett BS, Kessis TD, Williams BO, Jacks T, et al. p53-dependent G1 arrest involves pRB-related proteins and is disrupted by the human papillomavirus 16 E7 oncoprotein. Proc Natl Acad Sci U S A 1994;91:5320-4.
10. Geng Y, Eaton EN, Picon M, Roberts JM, Lundberg AS, Gifford A, et al. Regulation of cyclin E transcription by E2Fs and retinoblastoma protein. Oncogene 1996;12:1173-80.
11. Botz J, Zerfass-Thome K, Spitkovsky D, Delius H, Vogt B, Eilers M, et al. Cell cycle regulation of the murine cyclin E gene depends on an E2F binding site in the promoter. Mol Cell Biol 1996;16:3401-9.
12. Martin LG, Demers GW, Galloway DA. Disruption of the G1/S transition in human papillomavirus type 16 E7-expressing human cells is associated with altered regulation of cyclin E. J Virol 1998;72:975-85.
13. Zerfass K, Schulze A, Spitkovsky D, Friedman V, Henglein B, Jansen-Durr P. Sequential activation of cyclin E and cyclin A gene expression by human papillomavirus type 16 E7 through sequences necessary for transformation. J Virol 1995;69:6389-99.
14. Prasad CJ, Genest DR, Crum CP. Nondiagnostic squamous atypia of the cervix (atypical squamous epithelium of undetermined significance): histologic and molecular correlates. Int I Gynaecol Pathol 1994;13:220-7.
15. Jovanovic AS, McLachlin CM, Shen L, Welch WR, Crum CP. Postmenopausal squamous atypia: a spectrum including "pseudokoilocytosis." Mod Pathol 1995;8:408-12.
16. Dutta A, Chandra R, Leiter LM, Lester S. Cyclins as markers of tumor proliferation: immunocytochemical studies in breast cancer. Proc Natl Acad Sci U S A 1995;92:5386-90.
17. Genest DR, Stein L, Cibas E, Sheets E, Zitz JC, Crum CP. A binary (Bethesda) system for classifying cervical cancer precursors: criteria, reproducibility, and viral correlates. Hum Pathol 1993;24:730-6.
18. Manos MM, Ting Y, Wright DK, Lewis AJ, Broker TR, Wolinsky SM. Use of polymerase chain reaction amplification for the detection of genital human papillomaviruses. In: Furth H, Greaves H, editors. Cancer cells: molecular diagnosis of human cancer. Vol 7. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory, 1989. p. 209-14.
19. de Villiers EM. Heterogeneity of the human papillomavirus group. J Virol 1989;63:4898-903.
20. Meyers G, Baker C, Münger K, Sverdup F, McBride A, Bernard H-U, editors. Human papillomaviruses 1997: a compilation and analysis of nucleic acid and amino acid sequence. Los Alamos, NM: Los Alamos National Laboratory; 1997. p. I-1 to II-LCR-21.
21. Lorincz AT, Reid R, Jenson AB, Greenberg MD, Lancaster W, Kurman RJ. Human papillomavirus infection of the cervix: relative risk associations of 15 common anogenital types. Obstet Gynecol 1992;79:328-37.
22. Lindgren A, Stendahl U, Nordlinder H, Busch C. Blood group isoantigen and involucrin expression in cervical intraepithelial neoplasia. Anticancer Res 1987;7:243-6.
23. Smedts F, Ramaekers F, Robben H, Pruszczynski M, van Muijen G, Lane B, et al. Changing patterns of keratin expression during progression of cervical intraepithelial neoplasia. Am J Pathol 1990;136:657-68.
24. Smedts F, Ramaekers F, Troyanovsky S, Pruszczynski M, Robben H, Lane B, et al. Basal-cell keratins in cervical reserve cells and a comparison to their expression in cervical intraepithelial neoplasia. Am J Pathol 1992;140:601-12.
25. Smedts F, Ramaekers F, Leube RE, Keijser K, Link M, Vooijs P. Expression of keratins 1, 6, 15, 16, and 20 in normal cervical epithelium, squamous metaplasia, cervical intraepithelial neoplasia, and cervical carcinoma. Am J Pathol 1993; 142:403-12.
26. Elsayed A, Richart RM, Crum CP. Involucrin expression in cervical intraepithelial neoplasia: a critical evaluation. Gynecol Oncol 1987;26:25-34.
27. Agnantis NJ, Mahera H, Maounis N, Papanicolaou A, Spandidos DA. Ras p21 oncoprotein: expression in human cervical intraepithelial neoplasias and other benign conditions of the uterine cervix. Adv Appl Biotechnol Ser 1990;6:97-101.
28. Nakao Y, Yang X, Yokoyama M, Ferenczy A, Tang SC, Pater MM, et al. Induction of p16 during immortalization by HPV 16 and 18 and not during malignant transformation. Br J Cancer 1997;75:1410-6.
29. Nichols GE, Williams ME, Gaffey MJ, Stoler MH. Cyclin D1 gene expression in human cervical neoplasia. Mod Pathol 1996;9:418-25.
30. Mittal KR, Demopoulos RI, Goswami S. Proliferating cell nuclear antigen (cyclin) expression in normal and abnormal cervical squamous epithelia. Am J Surg Pathol 1993;17:117-22.
31. Amortegui AJ, Meyer MP, Elborne VL, Amin RM. p53, retinoblastoma gene product, and cyclin protein expression in human papillomavirus virus DNA-positive cervical intraepithelial neoplasia and invasive cancer. Mod Pathol 1995;8: 907-12.
32. Mashal RD, Lester S, Corless C, Richie JP, Chandra R, Propert KJ, et al. Expression of cell cycle-regulated proteins in prostate cancer. Cancer Res 1996;56:4159-63.
33. McIntyre MC, Ruesch MN, Laimins LA. Human papillomavirus E7 oncoproteins bind a single form of cyclin E in a complex with cdk2 and p107. Virology 1996;215:73-82.
34. Stoler MH, Rhodes CR, Whitbeck A, Wolinsky SM, Chow LT, Broker TR. Human papillomavirus type 16 and 18 gene expression in cervical neoplasias. Hum Pathol 1992;23:117-28.
35. Cho NH, Kim YT, Kim JW. Correlation between G1 cyclins and HPV in the uterine cervix. Int J Gynaecol Pathol 1997; 16:339-47.